About Us
Careers
Partner with us
Forgot password?
Sign in
Login
Login
Email
Password
Forgot your password?
Join VuMedi
Select specialty
Your main specialty
Adult & Family Medicine
Allergy, Asthma, Immunology
Anesthesiology
Cardiovascular
Dental
Dermatology
Emergency Medicine
Endocrinology
Gastroenterology & Hepatology
General Surgery
Hematology & Oncology
Infectious Disease
Medical Genetics
Nephrology
Neurology
Neurosurgery
Obstetrics/Gynecology
Ophthalmology
Oral Maxillofacial
Orthopaedics
Otolaryngology
Pathology
Pediatrics
Physical Medicine & Rehab
Plastic Surgery
Podiatry
Preventive Medicine
Psychiatry
Pulmonology
Radiation Oncology
Radiology
Rheumatology
Urology
First name
Last name
Email
Choose Password
Treatment Considerations in KRAS NSCLC
Treatment Considerations in KRAS NSCLC
Playback speed
0.5x
0.75x
1x (Normal)
1.25x
1.5x
1.75x
2x
10 seconds
B
Direct KRAS Inhibition in NSCLC: Past, Present, and Future
By
Benjamin Herzberg
241 views
May 12, 2023
0 Comments
Login to view comments.
Click here to Login
Treatment Considerations in KRAS NSCLC
04:42
GRACE
NSCLC Panel Discussion: Should a Patient With High PD-L1 Wait for Ge…
Feat.
K. Higgins,
A. Desai,
J. Lin,
J. Reuss,
P. Iyengar
06:29
Insights from 2023 WCLC
WCLC 2023 Insights: "KRYSTAL-1 - Two-Year Follow-Up of Adagrasi…
Feat.
S. Gadgeel
21:16
GRACE
Targeted Therapies in Lung Cancer 2023: Translating Cancer Discovery…
Feat.
J. Sabari
14:45
Yale Cancer Center
KRAS G12C NSCLC Treatment Approach: Surveying OS Data, CNS Activity,…
Feat.
A. Nassar
07:34
Marcelo Negrao
Intracranial Efficacy of Adagrasib in Patients From the KRYSTAL-1 Tr…
17:07
Nebraska Oncology Society
NOS ASCO® 2023 Review: Targeting Advanced KRAS and EGFR Mutations in…
Feat.
V. Lam
18:14
Janakiraman Subramanian
Understanding KRAS G12C Positive Lung Cancer
09:17
Shirish Gadgeel
The Data on Novel KRAS G12C Inhibitors: Focus on Adagrasib
33:14
Benjamin Herzberg
Direct KRAS Inhibition in NSCLC: Past, Present, and Future
